In 2009, Cannabinoids as pharmacotherapies for neuropathic pain: nerve injury, diabetes, chemotherapeutic treatment, human immunodeficiency virus, multiple sclerosis, and herpes zoster infection is considered.

Background: review of clinical and preclinical literature evaluating CB1, CB2, THC

You can read the full article here =>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755639/